Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
Watch for a break of 3.80 Stop signal 3.43. First target 4.43., Second target Momentum
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
Third time touching the trend line, breaking out of wedge, target 50% gain from here.
This will be a good stock to look in the morning at open if you're the type to short stocks.ADVM had some great gains today because they had news released this morning. These penny stocks usually tend to move up for any reason and then drop the next day. On top of that it has also hit some resistance.ADVM will be worth to look at tomorrow morning at open. Quote:...